Back to Search Start Over

Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes

Authors :
Antonella Accardo
Paola Ringhieri
Roberta Iannitti
Rosanna Palumbo
Giancarlo Morelli
Chiara Nardon
Dolores Fregona
Ringhieri, Paola
Roberta, Iannitti
Chiara, Nardon
Rosanna, Palumbo
Dolores, Fregona
Morelli, Giancarlo
Accardo, Antonella
Source :
International journal of pharmaceutics, 473 (2014): 194–202. doi:10.1016/j.ijpharm.2014.07.014, info:cnr-pdr/source/autori:Ringhieri P.; Iannitti R.; Nardon C.; Palumbo R.; Fregona D.; Morelli G.; Accardo A./titolo:Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes/doi:10.1016%2Fj.ijpharm.2014.07.014/rivista:International journal of pharmaceutics (Print)/anno:2014/pagina_da:194/pagina_a:202/intervallo_pagine:194–202/volume:473
Publication Year :
2014

Abstract

Pure sterically stabilized micelles (SSM) of DSPE-PEG2000, and sterically stabilized mixed micelles (SSMM) containing PC or DOPC phospholipids (5, 10 or 20% mol/mol with respect to DSPE-PEG2000) are developed as delivery systems for the gold based cytotoxic drug Au(III)-dithiocarbamato complex AuL12. In particular, SSMM containing 5% of PC at 5 mM of lipid concentration encapsulates 61.0 ?g of AuL12 with a DL% of 1.13. The gold complex remains stable up to 72 h when incorporated in the aggregate, as indicated by UV-vis measurements. Incorporation in micelle composition of a low amount of the peptide derivative MonY-BN-AA1, containing a bombesin peptide analogue does not influence structural parameters of the micelles (diameter around 20 nm) neither the AuL12 loading parameters. Target selective properties of the peptide containing full aggregate on PC-3 cells overexpressing the GRP/bombesin receptors are observed by in vitro cytotoxic studies: a decrease of cell viability, ~50%, is obtained in cells treated with AuL12-targeted micelles at 10 ?M drug concentration for 48 h with respect to untargeted micelles. © 2014 Elsevier B.V.

Details

ISSN :
18733476
Volume :
473
Issue :
1-2
Database :
OpenAIRE
Journal :
International journal of pharmaceutics
Accession number :
edsair.doi.dedup.....446d349cd7435aa0b7ba5cf5887109fb
Full Text :
https://doi.org/10.1016/j.ijpharm.2014.07.014